Medical artificial intelligence (AI) startup Yeji X (CEO Seong-Hyeon Jeong) announced on the 7th that it has been selected for the 'TIPS Global Track', a technology startup support program hosted by the Ministry of SMEs and Startups. This selection for Global TIPS was made upon the recommendation of Kakao Ventures, which led the seed investment.
The "TIPS Global Track" is a new program designed to support the overseas expansion of promising technology startups. It provides up to KRW 1.2 billion in research and development (R&D) funding over three years. Selection criteria include securing at least KRW 300 million in investment from the TIPS operator and meeting criteria related to global expansion, including overseas investment, sales achievement, overseas subsidiary ownership, and the signing of purchase agreements.
During the review process, YeziX received high marks for its core pipeline, the "Algorithm for Predicting Readmission Risk in Heart Failure Patients," which has high growth potential in the US market. Based on "multimodal AI" technology that integrates analysis of electronic health records (EHR) and medical images, the solution not only enables early disease diagnosis but also precisely predicts post-discharge patient deterioration and readmission risk.
In particular, YeziX's technology has been recognized as the starting point for a "Continuum of Care" system that extends beyond in-hospital treatment to the home and community after discharge. This meets the demands of the U.S. healthcare market for reduced readmission rates and reduced healthcare costs, and has been recognized for its value as a global exportable healthcare service model.
YeziX recently strengthened its R&D capabilities by recruiting Professor Yoonjae Choi of KAIST, a former Google Health Researcher, as a member of its Scientific Advisory Board. Professor Choi is expected to contribute to the development of a standardized prediction platform that efficiently processes complex EHR data and operates reliably in diverse healthcare environments.
“YejiX’s goal is to become an ‘infrastructure layer’ that enables hospitals to improve their finances and operational efficiency, starting with our heart failure readmission prediction solution,” said Jeong Seong-hyeon, CEO of YejiX. “We will use this selection as a stepping stone to lead the field of readmission risk prediction.”
- See more related articles
You must be logged in to post a comment.